STAT3-mediated S1PR1 upregulation, facilitated by sphingosine-1-phosphate (S1P) and IL-6, contributes in turn to sustain STAT3 activity in both tumor cells and in the tumor stromal cells, thereby promoting malignant progression. Here, IL6 is linked to neoplasm.